Neoadjuvant chemotherapy in the treatment of stage II and III breast cancer
- 1 October 2001
- journal article
- Published by Elsevier in The American Journal of Surgery
- Vol. 182 (4) , 341-346
- https://doi.org/10.1016/s0002-9610(01)00724-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Prognostic Implications of Pathological Lymph Node Status After Preoperative Chemotherapy for Operable T3N0M0 Breast CancerAnnals of Surgical Oncology, 2000
- The feasibility of minimally invasive surgery for Stage IIA, IIB, and IIIA breast carcinoma patients after tumor downstaging with induction chemotherapyCancer, 2000
- Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast CancerJournal of Clinical Oncology, 1999
- Conservation Surgery After Primary Chemotherapy in Large Carcinomas of the BreastAnnals of Surgery, 1995
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Conservative treatment feasibility with induction chemotherapy, surgery, and radiotherapy for patients with breast carcinoma larger than 3 cmCancer, 1994
- Mastectomy Following Preoperative Chemotherapy Strict Operative Criteria Control Operative MorbidityAnnals of Surgery, 1991
- Results of neoadjuvant chemotherapy and radiation therapy in the breast-conserving treatment of 250 patients with all stages of infiltrative breast cancerCancer, 1990
- The Prognostic Significance of Lymph Node Metastases After Preoperative Chemotherapy for Locally Advanced Breast CancerArchives of Surgery, 1989
- Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapyCancer, 1988